Vanda

Quote

fedupinthefield said:
You may be on to something. When did Milhalis hire a third kid? What is Medical Analytics? Is he doing our IC number crunching now too with Yanni?

What do you all think? Is this compensation “consistent with the compensation offered to other employees” who had no industry experience before working for the family business?

From shareholder docs:

Other Related Party Transactions

On October 6, 2014, Christos Polymeropoulos, M.D., the son of our Chief Executive Officer, Mihael Polymeropoulos, M.D., commenced employment with the Company as a Medical Director. Christos Polymeropoulos, M.D. was promoted to Pharmacovigilance Medical Director and Program Lead with an annual salary effective March 1, 2017 of $200,000 a target bonus of 20% of his annual salary. His salary increased to $210,000 effective March 1, 2018. In connection with the commencement of his employment, he received (i) a grant of options to purchase 16,500 shares of the Company’s common stock, with an exercise price of $9.59 per share, the closing price per share of the Company’s common stock on The Nasdaq Global Market on the date he commenced employment and (ii) an RSU grant covering 6,500 shares of common stock. In March 2017, he received an RSU grant covering 8,438 shares of common stock relating to 2016 performance. In February 2018, he received an RSU grant covering 8,438 shares of common stock relating to 2017 performance. The shares subject to the options and the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.

On September 29, 2014, Katerina Polymeropoulos, the daughter of our Chief Executive Officer, Mihael Polymeropoulos, M.D., commenced employment with the Company as Health Educator. She was promoted to Marketing Coordinator in March 2017. Her annual salary effective March 1, 2017 was $78,000 and she had a target bonus of 7.5% of her annual salary. Her salary increased to $80,340 effective March 1, 2018. Katerina Polymeropoulos received an RSU grant covering 3,375 shares of common stock in March 2017 relating to 2016 performance. In February 2018, Katerina Polymeropoulos received an RSU grant covering 3,375 shares of common stock relating to 2017 performance. The shares subject to the options and the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.

On February 12, 2018, Vasilios Polymeropoulos, M.D., the son of our Chief Executive Officer, Mihael Polymeropoulos, M.D., commenced employment with the Company as a Director of Medical Analytics. His annual salary for 2018 is $145,000 and has a target bonus of 17.5% of his annual salary. In connection with the commencement of his employment, he received an RSU grant covering 4,000 shares of common stock. The shares subject to the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.
Click to expand...
But, we are owned by the Polymeropolous family. Oh wait, we are a publicly traded company with a board of directors allowing this nepotism. while the ruler acts like Vanda is still his private empire. The Poly children should be looking for employment as the days are numbered before daddy hits the press for charging $165000 per year for melatonin.
 


And the poly kids get stock while the rest of employees are told " it is coming". Vanda is the company that Martin Shkreli, pharma bro, was looking to create. But he is prison bound. Will Mihales be his room mate?
 


but we don’t even know after almost 6 weeks into Q2 what we are being compensated?? Watch they will tell us it is still being worked on and we should have it in writing when Q2 is over just like the first Q. If you want hetlioz prescriptions than give us our full fanapt bonus and bring back Q4 hetlioz bonus. Otherwise keep waiting as only 3 people bring intakes in and the rest just laugh at them, because one day someone will investigate these red flag reps and Dr P will throw them under the bus. It won’t be him getting in trouble it will be the reps. Watch your backs.
 


anonymous said:
Presidents club winners have gotten nothing for 2017. That is complete shit. It is April. Although some now have the "skills letter" because of Hetlioz. There is a special place in hell for heartless fucktards like Dr Poly, GP and Tom.
Click to expand...
Winners circle finally acknowledged by Tom today but they are "still working on" what that means. Rewards for 2017 winners circle should have been known in March 2017 not May 2018. and yet senior leadership wonders why everyone hates working for Vanda. Rewards for 2018 winners circle should have been known 4months ago but yet will not be determined until next year........ Worst imitation of a real pharma company ever!!
 




Tom: why are you not meeting your goals for hetlioz or Fanapt?
Rep: I am working on it. Don’t know when it will change, but will work on it and let you know.
Haha we should start saying this to him.
 


In March 2017, he (Christos) received an RSU grant covering 8,438 shares of common stock relating to 2016 performance. In February 2018, he received an RSU grant covering 8,438 shares of common stock relating to 2017 performance. The shares subject to the options and the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.

Katerina Polymeropoulos received an RSU grant covering 3,375 shares of common stock in March 2017 relating to 2016 performance. In February 2018, Katerina Polymeropoulos received an RSU grant covering 3,375 shares of common stock relating to 2017 performance. The shares subject to the options and the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.

In connection with the commencement of his employment, he received an RSU grant covering 4,000 shares of common stock. The shares subject to the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.
-----------------------------------------

Katerina was a Health Educator and the Marketing Coordinator and the company aka Big Daddy Poly actually says that the shares and RSU's are consistent with those offered to other employees. THIS IS A BOLD FACED LIE that is part of an SEC filing!!!! Reps and many other employees that are not family members were told this was coming and have since seen and heard and received ZERO. That is NOT consistent.

The measy raises and the bonuses that were cut retroactive to the quarter is the NORM. The Poly kids didn't get the same treatment at all. There is NO consistency, just blatant nepotism.





 


Got a strange phone call this afternoon from a “law firm” asking about my role at Vanda and asking if I’d be available for a few minutes to talk. I was driving so I used that as a reason to jump off call. Should I have just directed to home office?
Btw, just a coincidence or could it be tied in with the document hold notice we got this afternoon? Thoughts guy?
 










anonymous said:
In March 2017, he (Christos) received an RSU grant covering 8,438 shares of common stock relating to 2016 performance. In February 2018, he received an RSU grant covering 8,438 shares of common stock relating to 2017 performance. The shares subject to the options and the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.

Katerina Polymeropoulos received an RSU grant covering 3,375 shares of common stock in March 2017 relating to 2016 performance. In February 2018, Katerina Polymeropoulos received an RSU grant covering 3,375 shares of common stock relating to 2017 performance. The shares subject to the options and the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.

In connection with the commencement of his employment, he received an RSU grant covering 4,000 shares of common stock. The shares subject to the RSUs include vesting provisions consistent with those offered to other employees. Such compensation is consistent with the compensation offered to the Company’s other employees upon the commencement of employment.
-----------------------------------------

Katerina was a Health Educator and the Marketing Coordinator and the company aka Big Daddy Poly actually says that the shares and RSU's are consistent with those offered to other employees. THIS IS A BOLD FACED LIE that is part of an SEC filing!!!! Reps and many other employees that are not family members were told this was coming and have since seen and heard and received ZERO. That is NOT consistent.

The measy raises and the bonuses that were cut retroactive to the quarter is the NORM. The Poly kids didn't get the same treatment at all. There is NO consistency, just blatant nepotism.




Click to expand...

You all are missing the craziest part. If you look at older shareholder documents you will see that Christos’s salary was 145k in the end of 2014. Taken together with his increase in bonus percent he has had an increase/raise of OVER 50% in the less than 3.5 years he has been at Vanda.

Not to mention as you have pointed out that this is before considering all the stock the kids are getting compared to the rest of us.

Does anyone even know what he is doing? They say publicly that he is doing clinical/safety work but I get the impression he is mainly involved in commercial and driving some of these crazy ideas.
 


anonymous said:
You all are missing the craziest part. If you look at older shareholder documents you will see that Christos’s salary was 145k in the end of 2014. Taken together with his increase in bonus percent he has had an increase/raise of OVER 50% in the less than 3.5 years he has been at Vanda.

Not to mention as you have pointed out that this is before considering all the stock the kids are getting compared to the rest of us.

Does anyone even know what he is doing? They say publicly that he is doing clinical/safety work but I get the impression he is mainly involved in commercial and driving some of these crazy ideas.
Click to expand...

Wow...
 


this will make you all laugh... or cry... and should definitely be sent to CNN... or whatever law firms are contacting you:

https://www.hipaaspace.com/medical_...provider_identifier/codes/npi_1871937953.aspx

Looks like Christos was practicing medicine from an office located at 2200 Pennsylvania Ave, suite 300 E, in Washington DC. Now, doesn't that sound familiar? Oh, that's right, that is the Vanda headquarters!

The best part, though, is it lists a phone number. I was hoping it would be a corporate Vanda office number, but it looks like a cell phone number... you should all start calling Christos and ask him about his pay and all of the questions and comments you are discussing here. I sure he would love that! Send it to the reports, lawyers, let's all take a day off work and have a "call christos" day!

Enjoy!
 


anonymous said:
Call CNN they would like to hear from you. Google "little red pill" That reporter will be up the Polly family's ass in no time.
Click to expand...
CNN called the little red pill (Nuedexta) expensive at $12.60 per pill. What does that make Hetlioz at $479 per pill? Avanir is in very hot water for pushing use in patients without clinical data to support. Again, sounds like our being pushed to get Hetlioz used in sighted patients, without any clinical data to support the usage in sighed patients. It's only a matter of time before Hetlioz hits the news for improper promotion.

Dr: show me some data for Hetlioz use in patients other than blind patients
Rep: doctor, I'm sure that data is on it's way at the same speed as fanapt and new indications
Dr: get out
 


at what point are the field sales team going to get any IC plan for second quarter or data? We are making them money on a daily basis and they can’t get their shit together enough to give us data? What is going on up there in HQ? Anyone??
 


anonymous said:
at what point are the field sales team going to get any IC plan for second quarter or data? We are making them money on a daily basis and they can’t get their shit together enough to give us data? What is going on up there in HQ? Anyone??
Click to expand...
waiting to see how sales are going and then design a plan that pays as few people as possible - Dr Greek is greedy and cheap.
 


anonymous said:
this will make you all laugh... or cry... and should definitely be sent to CNN... or whatever law firms are contacting you:

https://www.hipaaspace.com/medical_...provider_identifier/codes/npi_1871937953.aspx

Looks like Christos was practicing medicine from an office located at 2200 Pennsylvania Ave, suite 300 E, in Washington DC. Now, doesn't that sound familiar? Oh, that's right, that is the Vanda headquarters!

The best part, though, is it lists a phone number. I was hoping it would be a corporate Vanda office number, but it looks like a cell phone number... you should all start calling Christos and ask him about his pay and all of the questions and comments you are discussing here. I sure he would love that! Send it to the reports, lawyers, let's all take a day off work and have a "call christos" day!

Enjoy!
Click to expand...
Christos sent out announcement about Hetlioz and Jet Lag. Who really cares.

Patient : Doctor, I will be going on a trip in August. Should I take Hetlioz?
Doctor: September of what year?
Patient: 2018
Doctor: Ha Ha Ha. If I prescribe Hetlioz, there is about a 20% chance that the hub will not screw up and actually follow through on what they need to do. Then there is twenty percent chance that you will get your first overpriced pill by August. And then a ten percent chance it will start working within 2 or 3 months.
Patient: Wow, that sounds like a complete waste of everyone's time.
Doctor: You have no idea.
 


anonymous said:
Christos sent out announcement about Hetlioz and Jet Lag. Who really cares.

Patient : Doctor, I will be going on a trip in August. Should I take Hetlioz?
Doctor: September of what year?
Patient: 2018
Doctor: Ha Ha Ha. If I prescribe Hetlioz, there is about a 20% chance that the hub will not screw up and actually follow through on what they need to do. Then there is twenty percent chance that you will get your first overpriced pill by August. And then a ten percent chance it will start working within 2 or 3 months.
Patient: Wow, that sounds like a complete waste of everyone's time.
Doctor: You have no idea.
Click to expand...
So very true. Vanda took a broken system and thought that smashing it with a sledgehammer would make it work better. Triage rates plummeting thanks to poor leadership decisions.
 



Write your reply...
Top Bottom
Back
Quote